Immutep Limited Asset Resilience Ratio

Latest as of December 2025: 17.92%

Immutep Limited asset resilience ratio. Immutep Limited (YP1A) has an Asset Resilience Ratio of 17.92% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See YP1A defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€26.38 Million

≈ $30.84 Million USD Cash + Short-term Investments

Total Assets

€147.20 Million

≈ $172.09 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio of Immutep Limited (2023–2024)

Asset resilience ratio of Immutep Limited from 2023 to 2024. This chart shows how Immutep Limited's Asset Resilience Ratio has changed over time. Read Immutep Limited total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Immutep Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Immutep Limited asset portfolio.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€26.38 Million	17.92%
Total Liquid Assets	€26.38 Million	17.92%

Asset Resilience Insights

Good Liquidity Position: Immutep Limited maintains a healthy 17.92% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Immutep Limited Industry Peers by Asset Resilience Ratio

Compare Immutep Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Chengdu Easton Biopharmaceuticals Co Ltd SHG:688513	Biotechnology	35.16%
China Resources Boya Bio pharmaceutical Group Co Ltd SHE:300294	Biotechnology	23.15%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Achieve Life Sciences Inc F:SP4P	Biotechnology	3.60%

Immutep Limited Asset Resilience Ratio by Year (2023–2024)

Immutep Limited asset resilience ratio by year from 2023 to 2024. The table below shows the annual Asset Resilience Ratio data for Immutep Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-06-30	9.96%	€20.09 Million ≈ $23.48 Million	€201.58 Million ≈ $235.67 Million	--
2023-06-30	0.00%	€0.00 ≈ $0.00	€147.45 Million ≈ $172.38 Million	--

pp = percentage points

About Immutep Limited

F:YP1A Germany Biotechnology

Market Cap

$475.53 Million

€406.75 Million EUR

Market Cap Rank

#22118 Global

#1947 in Germany

Share Price

€2.76

Change (1 day)

-2.13%

52-Week Range

€0.21 - €4.05

All Time High

€4.52